Back to Agenda
[V6-S2] Drug Discovery and Development through Rare/Intractable Disease Research
Session Chair(s)
Shigeki Kuzuhara, MD, PHD
Dean, Graduate School of Health Science and Professor, School of Nursing, Suzuka University of Medical Science, Japan
In rare/intractable disease research, “the Plan for Promotion of Medical R&D” prescribed by the Japanese government promotes various approaches toward development of drugs, treatment, and disease prevention, including construction of a comprehensive medical system for diagnosing patients with rare/undiagnosed diseases (the Initiative on Rare and Undiagnosed Diseases: IRUD), research using disease-specific iPS cells, AMED’s cooperation with the International Rare Diseases Research Consortium (IRDiRC), etc. In this session, experts will provide a brief introduction to the current status and approaches of rare/intractable diseases research in Japan, and discuss issues to be addressed and future perspectives in rare/intractable disease research, drug discovery, and development.
Speaker(s)
Shigeki Kuzuhara, MD, PHD
Dean, Graduate School of Health Science and Professor, School of Nursing, Suzuka University of Medical Science, Japan
"Overcome Nan-Byo Project" of AMED - Innovational Research and Development against Rare / Intractable Diseases
Tatsutoshi Nakahata, MD, PHD
Deputy Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Elucidating Intractable Disease Mechanisms and Conducting Drug Discovery Using iPS Cell Techniques
Koh Nakata, MD, PHD
Professor, Director of Bioscience Medical Research Center, Niigata University Medical Dental Hospital, Japan
Strategy for Development of New Drug against Intractable Rare Diseases
Michihiko Wada, MD, PHD
Professor, Clinical and Translational Research Center, Keio University, Japan
Investigator-Sponsored Research and Patient Centricity Bridging from Academia to Industry
Have an account?